General information about company

Scrip code*506618
NSE Symbol*PUNJABCHEM
MSEI Symbol*NOTLISTED
ISIN*INE277B01014
Name of companyPunjab Chemicals and Crop Protection Limited
Type of companyMain Board
Class of securityEquity
Date of start of financial year01-04-2026
Date of end of financial year31-03-2027
Date of board meeting when results were approved03-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange19-10-2026
Description of presentation currencyINR
Level of roundingLakhs
Reporting TypeQuarterly
Reporting QuarterSecond quarter
Nature of report standalone or consolidatedConsolidated
Whether results are audited or unaudited for the quarter endedUnaudited
Whether results are audited or unaudited for the Year to date for current period ended/year endedUnaudited
Segment ReportingSingle segment
Description of single segmentPerformance Chemicals
Start date and time of board meeting03-11-2026 12:45
End date and time of board meeting03-11-2026 13:30
Whether cash flow statement is applicable on companyYes
Type of cash flow statementCash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualificationNot applicable



Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-07-202601-04-2026
Date of end of reporting period30-09-202630-09-2026
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations3267067394
Other income239111
Total income3290967505
2Expenses
(a)Cost of materials consumed2027540260
(b)Purchases of stock-in-trade77150
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade11863139
(d)Employee benefit expense 27966210
(e)Finance costs567978
(f)Depreciation, depletion and amortisation expense7981530
(g)Other Expenses
1Other Expenses538110403
Total other expenses538110403
Total expenses3108062670
3Total profit before exceptional items and tax18294835
4Exceptional items 00
5Total profit before tax18294835
6Tax expense
7Current tax4401186
8Deferred tax4396
9Total tax expenses4831282
10Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement00
11Net Profit Loss for the period from continuing operations13463553
12Profit (loss) from discontinued operations before tax00
13Tax expense of discontinued operations00
14Net profit (loss) from discontinued operation after tax00
15Share of profit (loss) of associates and joint ventures accounted for using equity method00
16Total profit (loss) for period13463553
17Other comprehensive income net of taxes-8129
18Total Comprehensive Income for the period12653582
19Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21Details of equity share capital
Paid-up equity share capital12261226
Face value of equity share capital1010
22Reserves excluding revaluation reserve
23Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations10.9828.98
Diluted earnings (loss) per share from continuing operations10.9828.98
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations00
Diluted earnings (loss) per share from discontinued operations00
iiiEarnings per equity share (for continuing and discontinued operations)
Basic earnings (loss) per share from continuing and discontinued operations10.9828.98
Diluted earnings (loss) per share from continuing and discontinued operations10.9828.98
24Debt equity ratioTextual Information( 1)
25Debt service coverage ratioTextual Information( 2)
26Interest service coverage ratioTextual Information( 3)
27Disclosure of notes on financial resultsTextual Information(4)

Text Block

Textual Information(4)Notes:

1.The above Unaudited Consolidated Statement of Financial Results for the quarter and half year ended 30 September 2026 were reviewed by the Audit Committee and have been approved by the Board of Directors at their respective meetings held on 3 November, 2026 and have been subjected to Limited Review by the Statutory Auditors. The review report of the Statutory Auditors is being filed with the BSE Limited and National Stock Exchange of India Limited. For more details, visit the Investor section of our website at www.punjabchemicals.com and Financial Results at Corporate section of www.bseindia.com and www.nseindia.com.

2.These Unaudited Consolidated Statement of Financial Results have been prepared in accordance with Indian Accounting Standards (‘Ind AS’) prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.

3.The Unaudited Consolidated Statement of Financial Results have been prepared by consolidating the financial results of Punjab Chemicals and Crop Protection Limited (“the Company”) for respective periods, with the financial results of its wholly owned subsidiary (WOS) viz. SD Agchem (Europe) N.V. The Company and its WOS is hereinafter collectively referred to as “the Group”.

4.The Group is engaged in the single operating segment Performance Chemicals.

5.On 1 May 2026, the Board of Directors had recommended a final dividend of Rs.3.00 (30%) per equity share (face value of Rs.10 per equity share) aggregating Rs. 368 lakh for the financial year ended 31 March 2026, which has been approved by the shareholders in the Annual General Meeting held on 31 July, 2026. Accordingly, Rs.368 lakhs was appropriated as distribution to equity shareholders of the Holding Company during the quarter ended 30 September 2026.

6.The Unaudited Consolidated Statement of Financial Results are rounded to the nearest lakh, except when otherwise indicated.



Statement of Asset and Liabilities

ParticularsHalf Year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2026
Date of end of reporting period30-09-2026
Whether results are audited or unauditedUnaudited
Nature of report standalone or consolidatedConsolidated
Assets
1 Non-current assets
Property, plant and equipment28149
Capital work-in-progress1528
Investment property0
Goodwill0
Other intangible assets276
Intangible assets under development124
Biological assets other than bearer plants0
Investments accounted for using equity method0
Non-current financial assets
Non-current investments175
Trade receivables, non-current0
Loans, non-current0
Other non-current financial assets
1Other non-current financial assets537
2
3
4
5
Details of other non-current financial assets
Total of other non-current financial assets537
Total non-current financial assets712
Deferred tax assets (net)0
Other non-current assets
1other tax assets (net)157
2other non-current assets599
3
4
5
Details of other non-current assets
Total of other non-current assets756
Total non-current assets31545
2Current assets
Inventories21323
Current financial asset
Current investments0
Trade receivables, current45392
Cash and cash equivalents987
Bank balance other than cash and cash equivalents821
Loans, current31
Other current financial assets
1Other current financial assets2274
2
3
4
5
Details of other current financial assets
Total of Other current financial assets2274
Total current financial assets49505
Current tax assets (net)0
Other current assets
1Other current assets2451
2
3
4
5
Details of other current assets
Total of other current assets2451
Total current assets73279
3Non-current assets classified as held for sale30
4Regulatory deferral account debit balances and related deferred tax Assets0
Total assets104854
Equity and liabilities
1Equity
Equity attributable to owners of parent
Equity share capital1226
Other equity44335
Total equity attributable to owners of parent45561
Non controlling interest0
Total equity45561
2Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current7887
Trade Payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises0
Total Trade payable0
Other non-current financial liabilities
1Other non-current financial liabilities196
2
3
4
5
Details of other non-current financial liabilities
Total of other non-current financial liabilities196
Total non-current financial liabilities8083
Provisions, non-current526
Deferred tax liabilities (net)1276
Deferred government grants, Non-current0
Other non-current liabilities
1
2
3
4
5
Details of other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities9885
Current liabilities
Current financial liabilities
Borrowings, current21659
Trade Payables, current
(A) Total outstanding dues of micro enterprises and small enterprises2790
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises18896
Total Trade payable21686
Other current financial liabilities
1Other current financial liabilities3618
2
3
4
5
Details of other current financial liabilities
Total of other current financial liabilities3618
Total current financial liabilities46963
Other current liabilities
1Other current liabilities622
2
3
4
5
Details of other current liabilities
Total of other current liabilities622
Provisions, current732
Current tax liabilities (Net)1091
Deferred government grants, Current
Total current liabilities49408
3Liabilities directly associated with assets in disposal group classified as held for sale0
4Regulatory deferral account credit balances and related deferred tax liability0
Total liabilities59293
Total equity and liabilities104854
Disclosure of notes on assets and liabilities

Other Comprehensive Income

Date of start of reporting period01-07-202601-04-2026
Date of end of reporting period30-09-202630-09-2026
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Other comprehensive income [Abstract]
1Amount of items that will not be reclassified to profit and loss
1Amount of items thal will not be reclassified to profit and loss-94.00-72.00
Total Amount of items that will not be reclassified to profit and loss-94.00-72.00
2Income tax relating to items that will not be reclassified to profit or loss -24.00-18.00
3Amount of items that will be reclassified to profit and loss
1Amount of items that will be reclassified to profit and loss-11.0083.00
Total Amount of items that will be reclassified to profit and loss-11.0083.00
4Income tax relating to items that will be reclassified to profit or loss 0.000.00
5Total Other comprehensive income-81.0029.00


Cash flow statement, indirect

ParticularsHalf Year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2026
Date of end of reporting period30-09-2026
Whether results are audited or unauditedUnaudited
Nature of report standalone or consolidatedConsolidated
Part IBlue color marked fields are non-mandatory.
1Statement of cash flows
Cash flows from used in operating activities
Profit before tax4835
2Adjustments for reconcile profit (loss)
Adjustments for finance costs978
Adjustments for decrease (increase) in inventories3254
Adjustments for decrease (increase) in trade receivables, current-24728
Adjustments for decrease (increase) in trade receivables, non-current0
Adjustments for decrease (increase) in other current assets0
Adjustments for decrease (increase) in other non-current assets0
Adjustments for other financial assets, non-current0
Adjustments for other financial assets, current-1108
Adjustments for other bank balances0
Adjustments for increase (decrease) in trade payables, current4515
Adjustments for increase (decrease) in trade payables, non-current0
Adjustments for increase (decrease) in other current liabilities0
Adjustments for increase (decrease) in other non-current liabilities0
Adjustments for depreciation and amortisation expense1530
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss0
Adjustments for provisions, current196
Adjustments for provisions, non-current0
Adjustments for other financial liabilities, current-75
Adjustments for other financial liabilities, non-current0
Adjustments for unrealised foreign exchange losses gains-220
Adjustments for dividend income0
Adjustments for interest income0
Adjustments for share-based payments0
Adjustments for fair value losses (gains)0
Adjustments for undistributed profits of associates0
Other adjustments for which cash effects are investing or financing cash flow0
Other adjustments to reconcile profit (loss)613
Other adjustments for non-cash items0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships0
Total adjustments for reconcile profit (loss)-15045
Net cash flows from (used in) operations-10210
Dividends received0
Interest paid0
Interest received0
Income taxes paid (refund)-270
Other inflows (outflows) of cash0
Net cash flows from (used in) operating activities-9940
3Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses0
Cash flows used in obtaining control of subsidiaries or other businesses0
Other cash receipts from sales of equity or debt instruments of other entities0
Other cash payments to acquire equity or debt instruments of other entities0
Other cash receipts from sales of interests in joint ventures0
Other cash payments to acquire interests in joint ventures0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships0
Proceeds from sales of property, plant and equipment69
Purchase of property, plant and equipment2824
Proceeds from sales of investment property0
Purchase of investment property0
Proceeds from sales of intangible assets0
Purchase of intangible assets0
Proceeds from sales of intangible assets under development0
Purchase of intangible assets under development0
Proceeds from sales of goodwill0
Purchase of goodwill0
Proceeds from biological assets other than bearer plants0
Purchase of biological assets other than bearer plants0
Proceeds from government grants0
Proceeds from sales of other long-term assets0
Purchase of other long-term assets0
Cash advances and loans made to other parties0
Cash receipts from repayment of advances and loans made to other parties0
Cash payments for future contracts, forward contracts, option contracts and swap contracts0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts0
Dividends received0
Interest received46
Income taxes paid (refund)0
Other inflows (outflows) of cash-150
Net cash flows from (used in) investing activities-2859
4Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries0
Payments from changes in ownership interests in subsidiaries0
Proceeds from issuing shares0
Proceeds from issuing other equity instruments0
Payments to acquire or redeem entity's shares0
Payments of other equity instruments0
Proceeds from exercise of stock options0
Proceeds from issuing debentures notes bonds etc0
Proceeds from borrowings14615
Repayments of borrowings398
Payments of lease liabilities146
Dividends paid366
Interest paid872
Income taxes paid (refund)0
Other inflows (outflows) of cash0
Net cash flows from (used in) financing activities12833
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes34
5Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents83
Net increase (decrease) in cash and cash equivalents117
Cash and cash equivalents cash flow statement at beginning of period870
Cash and cash equivalents cash flow statement at end of period987